Stay Flexible<br />By Rev Shark<br />RealMoney.com Contributor<br />7/9/2009 8:29 AM EDT <br /><br />The wise adapt themselves to circumstances, as water molds itself to the pitcher. <br />-- Chinese proverb<br /><br />The market is gapping up a little this morning as Alcoa's (AA) loss wasn't quite as big as expected and oil and commodities bounce after being drubbed the last few days. On the other hand, same-store sales reports are trickling in and overall are looking quite poor. More than half of the reports I see so far have missed already low consensus estimates. That is putting some pressure on retail, which helped lead the anemic bounce we saw on Wednesday. <br /><br />The most important thing about the market right now is that we have shifted into a downtrending mode. The Nasdaq is in better shape than the other indices, but the S&P 500 and the Russell 2000 are just barely clinging to support levels at the highs seen back in April. <br /><br />The big change is that we aren't seeing much interest at all in dip-buying. We did have a little last-hour jump on Wednesday, but it isn't anything like what we experienced back in May and June. Back then, once the dip-buying started, the underinvested bulls on the sidelines would start chasing us higher and that would squeeze the shorts and give us some strong upside momentum. Now it looks like the bears are gaining confidence and are lining up to short strength, and the bulls are looking for exit points. <br /><br />At this juncture, the market is still oversold and conditions are in place for some upside, but the weakness of the bounce attempt yesterday was troubling. All that we ended up with was some flat action that helped to alleviate the oversold pressure. <br /><br />Adjust your mindset. This is no longer a market where we can give a poor-performing long position room to prove itself. If it starts to falter, the danger is that it is going to accelerate to the downside and put you in a hole quickly. When stocks start to break down in a market that is rolling over, the easiest way to get in trouble is to wait for the overall market to bail you out. <br /><br />That doesn't mean there won't be some upside trades, but you have to think in terms of quick flips. Breakouts won't gain momentum like they do in a better market. There will be a few strong stocks here and there, but the hot pockets of momentum like we enjoyed in May and June will have very limited life spans. <br /><br />Change your mindset and you'll do just fine in navigating a market that is showing strong signs of a more sustained downtrend. Inflexibility is your biggest enemy. There is no question that the market is not acting as well as it was a month ago. Acknowledge and embrace that fact, and you'll be able to find new ways to profit. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance/SSS: COMS +7.4%, AA +7.1%, GYMB +6.1% (light volume), CHTT +4.1%, SCSC +3.9%, CPKI +3.3%, ARO +2.7%, ANF +2.0% (light volume)... M&A news: NTAP +4.4% (NetApp declines to revise bid for Data Domain; merger agreement terminated), IPCR +4.2% (IPC Holdings to be acquired by Validus for $7.50 in cash and 0.9727 Validus voting common shares)... Select metals/mining/commodity related names showing strength boosted by AA results: CENX +7.0%, AKS +5.7%, AAUK +5.2%, BBL +4.0%, BHP +3.4%, GOLD +3.1%, X +2.6%, MT +2.4%, ACH +2.3%, FCX +2.2%... Select financial names showing strength: SNV +7.5%, HBAN +5.9%, RBS +4.4% (ANZ Bank raises A$2.2 bln via share purchase plan - DJ), GS +2.2% (upgraded to Buy at BofA/Merrill), C +1.9%, BAC +1.9%... Select oil/gas related names trading higher: SNP +3.8%, PBR +2.4%, RDS.A +1.1%... Other news: RIGL +33.5% (Rigel Pharma's R788 significantly improves rheumatoid arthritis in Ph. 2b clinical trial ), NVAX +13.5% (Cadila Pharmaceuticals Launches Joint Venture With Novavax in India), HGSI +8.8% (says data published in The New England Journal of Medicine support use of Raxibacumab for the treatment of inhalation anthrax), SAY +7.7% (signs 5-year contract with GlaxoSmithKline - DJ), DNDN +6.4% (still checking), CME +2.7% (modestly rebounding from its past 2 day 30+ point drop), BEZ +2.5% (Cramer makes positive comments on MadMoney), GE +2.1% (still checking for anything specific), LVS +2.0% (reconfirms Singapore opening timeline), WAG +0.9% (increases quarterly dividend by 22.2% to 13.75 cents/share)... Analyst comments: KBH +3.7% (upgraded to Outperform at Credit Suisse), CPKI +3.4% (upgraded to Buy at B.Riley), SAP +2.9% (upgraded to Buy at BofA/Merrill), ICE +2.1% (upgraded to Neutral from Sell at Pali Capital), HOT +1.6% (upgraded to Market Perform at FBR Capital), RIMM +1.3% (upgraded to Buy from Hold at Kaufman), APA +1.0% (upgraded to Outperform from Underperform at Calyon).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance/SSS: SIMO -9.9% , VRGY -9.8% (also announces proposed $110 mln convertible senior notes offering), EXAC -7.6% , HOTT -7.4% , PLCE -3.8%, ATI -2.5% (also announces voluntary contribution to U.S defined benefit pension plan)... M&A news: ELX -15.5% (rejects Broadcom's $11 offer; also guides Q4 EPS to high end of range, revs slightly above consensus), DDUP -1.5% (agrees to be acquired by EMC for $33.50 per share, terminates merger agreement with NetApp; also downgraded to Neutral at Baird)... Other news: MAPP -18.6% (MAP Pharma announces termination of Pediatric Asthma Collaboration), KMT -5.8% (announces its intention to offer 6.5 mln shares of common stock), AIG -5.3% (still checking), RNST -3.1% (files shelf registration statement for $150 mln of securities)... Analyst comments: RNOW -1.9% (downgraded to Hold at Deutsche Bank).